-DOCSTART- -X- O
Abstract -X- _ O
Feline -X- _ O
infectious -X- _ O
peritonitis -X- _ O
( -X- _ O
FIP -X- _ O
) -X- _ O
is -X- _ O
a -X- _ O
fatal -X- _ O
disease -X- _ O
in -X- _ O
domestic -X- _ O
and -X- _ O
nondomestic -X- _ O
felids -X- _ O
caused -X- _ O
by -X- _ O
feline -X- _ B-P
coronavirus -X- _ I-P
( -X- _ I-P
FCoV -X- _ I-P
) -X- _ I-P
. -X- _ O
Currently -X- _ O
, -X- _ O
no -X- _ O
effective -X- _ O
vaccine -X- _ O
is -X- _ O
available -X- _ O
for -X- _ O
the -X- _ O
prevention -X- _ O
of -X- _ O
this -X- _ O
disease. -X- _ O
In -X- _ O
searching -X- _ O
for -X- _ O
agents -X- _ O
that -X- _ O
may -X- _ O
prove -X- _ O
clinically -X- _ O
effective -X- _ O
against -X- _ O
FCoV -X- _ O
infection,16 -X- _ O
compounds -X- _ O
were -X- _ O
screened -X- _ O
for -X- _ O
their -X- _ O
antiviral -X- _ O
activity -X- _ O
against -X- _ O
a -X- _ O
local -X- _ O
FCoV -X- _ O
strain -X- _ O
in -X- _ O
Felis -X- _ O
catus -X- _ O
whole -X- _ O
fetus-4 -X- _ O
cells. -X- _ O
The -X- _ O
results -X- _ O
showed -X- _ O
that -X- _ O
Galanthus -X- _ B-I
nivalis -X- _ I-I
agglutinin -X- _ I-I
( -X- _ I-I
GNA -X- _ I-I
) -X- _ I-I
and -X- _ I-I
nelfinavir -X- _ I-I
effectively -X- _ B-o
inhibited -X- _ I-o
FCoV -X- _ I-o
replication. -X- _ I-o
When -X- _ B-o
the -X- _ I-o
amount -X- _ I-o
of -X- _ I-o
virus -X- _ I-o
preinoculated -X- _ I-o
into -X- _ I-o
the -X- _ I-o
test -X- _ I-o
cells -X- _ I-o
was -X- _ I-o
increased -X- _ I-o
to -X- _ I-o
mimic -X- _ I-o
the -X- _ I-o
high -X- _ I-o
viral -X- _ I-o
load -X- _ I-o
present -X- _ I-o
in -X- _ I-o
the -X- _ I-o
target -X- _ I-o
cells -X- _ I-o
of -X- _ I-o
FIP -X- _ I-o
cats -X- _ I-o
, -X- _ I-o
GNA -X- _ I-o
and -X- _ I-o
nelfinavir -X- _ I-o
by -X- _ I-o
themselves -X- _ I-o
lost -X- _ I-o
their -X- _ I-o
inhibitory -X- _ I-o
effect. -X- _ I-o
However -X- _ O
, -X- _ O
when -X- _ B-o
the -X- _ I-o
two -X- _ I-o
agents -X- _ I-o
were -X- _ I-o
added -X- _ I-o
together -X- _ I-o
to -X- _ I-o
FCoV-infected -X- _ I-o
cells -X- _ I-o
, -X- _ I-o
a -X- _ I-o
synergistic -X- _ I-o
antiviral -X- _ I-o
effect -X- _ I-o
de -X- _ I-o
ned -X- _ I-o
by -X- _ I-o
complete -X- _ I-o
blockage -X- _ I-o
of -X- _ I-o
viral -X- _ I-o
replication -X- _ I-o
was -X- _ I-o
observed. -X- _ I-o
These -X- _ O
results -X- _ O
suggest -X- _ O
that -X- _ O
the -X- _ O
combined -X- _ O
use -X- _ O
of -X- _ O
GNA -X- _ O
and -X- _ O
nelfinavir -X- _ O
has -X- _ O
therapeutic -X- _ O
potential -X- _ O
in -X- _ O
the -X- _ O
prophylaxis -X- _ O
and -X- _ O
treatment -X- _ O
of -X- _ O
cats -X- _ O
with -X- _ O
early-diagnosed -X- _ O
FIP -X- _ O
. -X- _ O

